袁 颖,张国君,黄文河.乳房植入体相关性间变性大细胞淋巴瘤的诊疗策略[J].肿瘤学杂志,2019,25(7):663-668.
乳房植入体相关性间变性大细胞淋巴瘤的诊疗策略
Diagnosis and Treatment Strategy of Breast Implant Associated-Anaplastic Large Cell Lymphoma
投稿时间:2018-10-12  
DOI:10.11735/j.issn.1671-170X.2019.07.B016
中文关键词:  乳房植入体  间变性大细胞淋巴瘤  诊疗策略
英文关键词:breast implants  anaplastic large cell lymphoma  management
基金项目:
作者单位
袁 颖 厦门大学附属翔安医院 
张国君 厦门大学附属翔安医院 
黄文河 厦门大学附属翔安医院 
摘要点击次数: 1658
全文下载次数: 448
中文摘要:
      摘 要:乳房植入体相关性间变性大细胞淋巴瘤(BIA-ALCL)与乳房植入体有很强的相关性。BIA-ALCL可能会表现出与乳房相关的特殊皮肤改变。BIA-ALCL最有效的治疗方法是乳房植入体及其周围的纤维囊彻底切除,大多数患者预后良好。对BIA-ALCL正确的认识和及时诊断能够防止病情进一步发展。全文就乳腺癌术后、乳房整形术后植入体相关的BIA-ALCL的相关性皮肤特征,以及发病机制、治疗策略和预后进行探讨。
英文摘要:
      Abstract:Breast implant associated-anaplastic large cell lymphoma(BIA-ALCL) is a special type of T-cell lymphoma. Patients with BIA-ALCL may present specific breast skin changes. The complete surgical removal of the implant and total capsulectomy are effective treatment for BIA-ALCL and most patients have a favorable clinical outcome. Correct diagnosis and timely treatment of BIA-ALCL can prevent further development of the disease. This article summarizes the clinical manifestations,pathogenesis,prognosis and treatment strategy of BIA-ALCL related to breast reconstruction following total mastectomy.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器